Exp Clin Endocrinol Diabetes 2013; 121(04): 230-233
DOI: 10.1055/s-0033-1341428
Article
© J. A. Barth Verlag in Georg Thieme Verlag KG Stuttgart · New York

Effect of Pregabalin on Erectile Function and Penile NOS Expression in Rats with Streptozotocin-Induced Diabetes

Authors

  • S. Amany

    1   Associate Professor of Clinical pharmacology, Clinical Pharmacology Department, Faculty of Medicine, Mansoura ­University, Egypt
  • K. Heba

    2   Associate Professor of Medical Biochemistry, Medical Biochemistry Department, Faculty of Medicine, Mansoura University, Egypt
Further Information

Publication History

received 28 October 2012
first decision 22 February 2013

accepted 01 March 2013

Publication Date:
17 April 2013 (online)

Abstract

Objectives:

To investigate the effect of pregabalin on erectile function and on the penile expression of nitric oxide synthase (NOS) isoforms in diabetic rat models.

Methods:

Male Sprague-Dawley rats were injected with streptozotocin to induce diabetes mellitus. The rats with blood glucose levels above 300 mg/dL were selected for the study. Those were randomly divided into 2 groups (N=10 per group): i) EDDM (erectile dysfunction diabetes mellitus )group fed with saline and ii) EDDM+Pregabalin treated group receiving pregabalin (10 mg/k/day) by intragastric administration. 10 animals served as a control group and received no streptozotocin. 4 weeks later, the erectile function of the rats was assessed by recording frequency of erection after subcutaneous apomorphine (80 ug/kg) injection. Superoxide anion generation and the expression of mRNA of nNOS and eNOS were evaluated in corpora cavernosum tissue.

Results:

Penile erection, the expression of both nNOS, eNOS and superoxide generation were significantly decreased in pregabalin treated group compared to control group.

Conclusion:

Treatment with pregabalin for 4 weeks decreases superoxide production but cannot improve erectile dysfunction in diabetic rats probably by inhibiting Ca2  +  channel-mediated NOS activation.